INFORS HT Opens New Offices in the US
INFORS HT, a global leader in the production of shakers, bioreactors and bioprocess control software, opened new offices in the US.
INFORS HT has, until now, been represented in the US by ATR (Appropriate Technical Resources Inc.). From 1 January 1 2014, INFORS HT is going to take over this part of the ATR business — including its infrastructure, the existing customer relations, and full complement of staff.
To guarantee a seamless continuity of service to their customers, all sales and service offices as well as production teams will remain unchanged, as will any current contact personnel. By increasing its presence in the US, INFORS HT will not only expand its customer base but give its customers direct day-to-day contact with INFORS HT representatives and no longer via a third party.
Marcel Brauchli, CEO of INFORS HT, points out: “We’re proud of our new branches and look forward to having direct contact with our customers in the USA. We’re convinced that, in this way, we can improve customer relations and build more successful long term partnerships.”
This new direct contact will also bring about an added value to customers. They will have access to a committed team who have a wealth of experience, technical know-how and innovative thinking that is second-to-none.
The new CEO of Infors US Inc., Simon Egli, holds a master degree in biotechnology engineering from the University of Waedenswil (CH). Before joining INFORS HT at the headquarters in Switzerland, he worked in various bioprocess production and validation positions at a management level. He has been with INFORS HT for 3 years.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance